ArticleScientific reports2024

QSAR, ADMET, molecular docking, and dynamics studies of 1,2,4-triazine-3(2H)-one derivatives as tubulin inhibitors for breast cancer therapy.

Mohamed Moussaoui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.